{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T01:29:50Z","timestamp":1794274190874,"version":"4.9.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["6\/9-7(241)\/2020-ECD-II"],"award-info":[{"award-number":["6\/9-7(241)\/2020-ECD-II"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Folia Microbiol"],"DOI":"10.1007\/s12223-026-01597-w","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T07:22:32Z","timestamp":1790925752000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Linsitinib: a tyrosine kinase inhibitor with dual host-parasite targeting potential against leishmaniasis"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0543-7053","authenticated-orcid":false,"given":"Lalit","family":"Nharwal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0362-8691","authenticated-orcid":false,"given":"Mirza Adil","family":"Beg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5118-7424","authenticated-orcid":false,"given":"Rahul","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0767-1328","authenticated-orcid":false,"given":"Vivek Dhar","family":"Dwivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0740-8573","authenticated-orcid":false,"given":"Farhan Jalees","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2194-1534","authenticated-orcid":false,"given":"Angamuthu","family":"Selvapandiyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8890-8691","authenticated-orcid":false,"given":"Garima","family":"Chouhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"issue":"9","key":"1597_CR1","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1039\/d3ob02091f","volume":"22","author":"VS Agostino","year":"2024","unstructured":"Agostino VS, Buerdsell ML, Uliana SRB, Denny PW, Coelho AC, Steel PG (2024) Clemastine\/tamoxifen hybrids as easily accessible antileishmanial drug leads. Org Biomol Chem 22(9):1812\u20131820. https:\/\/doi.org\/10.1039\/d3ob02091f","journal-title":"Org Biomol Chem"},{"issue":"1","key":"1597_CR2","doi-asserted-by":"publisher","first-page":"13398","DOI":"10.1038\/s41598-023-40160-2","volume":"13","author":"PC Agu","year":"2023","unstructured":"Agu PC, Afiukwa CA, Orji OU, Ezeh EM, Ofoke IH, Ogbu CO, Ugwuja EI, Aja PM (2023) Molecular docking as a tool for the discovery of molecular targets of nutraceuticals in diseases management. Sci Rep 13(1):13398. https:\/\/doi.org\/10.1038\/s41598-023-40160-2","journal-title":"Sci Rep"},{"issue":"14","key":"1597_CR3","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1080\/17568919.2026.2684542","volume":"18","author":"MSM Al-Saleem","year":"2026","unstructured":"Al-Saleem MSM, Al-Humaidi JY, Rahhou AE, Mukhrish YE, Chagaleti BK, Itto A, Oubella MY, A., Haggam RA (2026) Novel isoxazole-(thio-) and semicarbazone hybrids as promising antibacterial and anticancer agents: synthesis, characterization, biological evaluation, and in silico validation. Future Med Chem 18(14):1797\u20131816. https:\/\/doi.org\/10.1080\/17568919.2026.2684542","journal-title":"Future Med Chem"},{"key":"1597_CR4","doi-asserted-by":"publisher","unstructured":"Ali R, Tabrez S, Akand SK, Rahman F, Husein A, Arish M, Alqahtani AS, Ahmed MZ, Husain M, Rub A (2021) Sesamol Induces Apoptosis-Like Cell Death in Leishmania donovani. Frontiers in Cellular and Infection Microbiology. 11. https:\/\/doi.org\/10.3389\/fcimb.2021.749420. https:\/\/www.frontiersin.org\/journals\/cellular-and-infection-microbiology\/articles\/","DOI":"10.3389\/fcimb.2021.749420"},{"issue":"29","key":"1597_CR5","doi-asserted-by":"publisher","first-page":"26399","DOI":"10.1039\/d5ra09902a","volume":"16","author":"A Altharawi","year":"2026","unstructured":"Altharawi A, Chagaleti BK, Alamri MA, Riadi Y, Aldakhil T, Moulay Youssef AI, Oubella A, Haggam RA (2026) Synthesis, molecular modelling, and evaluation of new mono- and bis-isoxazolines as antibacterial agents: in vitro and in silico analysis. RSC Adv 16(29):26399\u201326420. https:\/\/doi.org\/10.1039\/d5ra09902a","journal-title":"RSC Adv"},{"issue":"8","key":"1597_CR6","doi-asserted-by":"publisher","first-page":"e0012438","DOI":"10.1371\/journal.pntd.0012438","volume":"18","author":"NO Alves","year":"2024","unstructured":"Alves NO, Oshiro JA, Silva YC, Pacher GC, Casaril AE, Rizk YS, Uehara SNO, Paniago AMM, Andrade ILX, Arruda CCP, Oliveira AG (2024) VL-HIV co-infection with Leishmania containing skin lesions resembling para-kala-azar dermal leishmaniasis. PLoS Negl Trop Dis 18(8):e0012438. https:\/\/doi.org\/10.1371\/journal.pntd.0012438","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"1597_CR7","doi-asserted-by":"publisher","first-page":"e0258996","DOI":"10.1371\/journal.pone.0258996","volume":"16","author":"WE Amlabu","year":"2021","unstructured":"Amlabu WE, Amisigo CM, Antwi CA, Awandare GA, Gwira TM (2021) Some novel antileishmanial compounds inhibit normal cell cycle progression of Leishmania donovani promastigotes and exhibits pro-oxidative potential. PLoS ONE 16(11):e0258996. https:\/\/doi.org\/10.1371\/journal.pone.0258996","journal-title":"PLoS ONE"},{"key":"1597_CR8","doi-asserted-by":"publisher","unstructured":"Ara\u00fajo IAC, De Paula RC, Alves CL, Faria KF, de Oliveira MM, Takarada GGM, Dias EMFA, de Oliveira AB, Silva SM (2022) da. In vitro efficacy of isoflavonoids and terpenes against Leishmania (Leishmania) infantum and L. amazonensis. Experimental Parasitology, 242, 108383. https:\/\/doi.org\/10.1016\/j.exppara.2022.108383","DOI":"10.1016\/j.exppara.2022.108383"},{"key":"1597_CR9","doi-asserted-by":"publisher","unstructured":"Baker N, Catta-Preta CMC, Neish R, Sadlova J, Powell B, Alves-Ferreira EVC, Geoghegan V, Carnielli JBT, Newling K, Hughes C, Vojtkova B, Anand J, Mihut A, Walrad PB, Wilson LG, Pitchford JW, Volf P, Mottram JC (2021) Systematic functional analysis of Leishmania protein kinases identifies regulators of differentiation or survival. Nat Commun 12(1). https:\/\/doi.org\/10.1038\/s41467-021-21360-8","DOI":"10.1038\/s41467-021-21360-8"},{"key":"1597_CR10","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s10637-018-0574-0","volume":"36","author":"P Barata","year":"2018","unstructured":"Barata P, Cooney M, Tyler A, Wright J, Dreicer R, Garcia JA (2018) A phase 2 study of OSI-906 (linsitinib, an insulin-like growth factor receptor-1 inhibitor) in patients with asymptomatic or mildly symptomatic (non-opioid requiring) metastatic castrate resistant prostate cancer (CRPC). Investig New Drugs 36:451\u2013457","journal-title":"Investig New Drugs"},{"issue":"14","key":"1597_CR11","doi-asserted-by":"publisher","first-page":"7740","DOI":"10.1021\/acs.jmedchem.0c00570","volume":"63","author":"AS Bell","year":"2020","unstructured":"Bell AS, Yu Z, Hutton JA, Wright MH, Brannigan JA, Paape D, Roberts SM, Sutherell CL, Ritzefeld M, Wilkinson AJ (2020) Novel thienopyrimidine inhibitors of Leishmania N-myristoyltransferase with on-target activity in intracellular amastigotes. J Med Chem 63(14):7740\u20137765","journal-title":"J Med Chem"},{"issue":"1","key":"1597_CR12","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The Protein Data Bank. Nucleic Acids Res 28(1):235\u2013242. https:\/\/doi.org\/10.1093\/nar\/28.1.235","journal-title":"Nucleic Acids Res"},{"issue":"22","key":"1597_CR13","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.1182\/blood-2009-10-251082","volume":"115","author":"AP Bhatt","year":"2010","unstructured":"Bhatt AP, Bhende PM, Sin S-H, Roy D, Dittmer DP, Damania B (2010) Dual inhibition of PI3K and mTOR inhibits autocrine and paracrine proliferative loops in PI3K\/Akt\/mTOR-addicted lymphomas. Blood 115(22):4455\u20134463. https:\/\/doi.org\/10.1182\/blood-2009-10-251082","journal-title":"Blood"},{"key":"1597_CR14","doi-asserted-by":"publisher","first-page":"122844","DOI":"10.1016\/j.lfs.2024.122844","volume":"351","author":"A Bhattacharjee","year":"2024","unstructured":"Bhattacharjee A, Bagchi A, Sarkar S, Bawali S, Bhattacharya A, Biswas A (2024) Repurposing approved protein kinase inhibitors as potent anti-leishmanials targeting Leishmania MAP kinases. Life Sci 351:122844. https:\/\/doi.org\/10.1016\/j.lfs.2024.122844","journal-title":"Life Sci"},{"key":"1597_CR15","doi-asserted-by":"publisher","unstructured":"Bowers KJ, Chow DE, Xu H, Dror RO, Eastwood MP, Gregersen BA, Klepeis JL, Kolossvary I, Moraes MA, Sacerdoti FD, Salmon JK, Shan Y, Shaw DE (2006) Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters. ACM\/IEEE SC 2006 Conference (SC\u201906), 54. https:\/\/doi.org\/10.1109\/SC.2006.54","DOI":"10.1109\/SC.2006.54"},{"issue":"6","key":"1597_CR17","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s12551-021-00855-0","volume":"13","author":"JA Brannigan","year":"2021","unstructured":"Brannigan JA, Wilkinson AJ (2021) Drug discovery in leishmaniasis using protein lipidation as a target. Biophys Rev 13(6):1139\u20131146. https:\/\/doi.org\/10.1007\/s12551-021-00855-0","journal-title":"Biophys Rev"},{"issue":"4","key":"1597_CR16","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1016\/j.jmb.2009.12.032","volume":"396","author":"JA Brannigan","year":"2010","unstructured":"Brannigan JA, Smith BA, Yu Z, Brzozowski AM, Hodgkinson MR, Maroof A, Price HP, Meier F, Leatherbarrow RJ, Tate EW, Smith DF, Wilkinson AJ (2010) N-myristoyltransferase from Leishmania donovani: structural and functional characterisation of a potential drug target for visceral leishmaniasis. J Mol Biol 396(4):985\u2013999. https:\/\/doi.org\/10.1016\/j.jmb.2009.12.032","journal-title":"J Mol Biol"},{"issue":"2","key":"1597_CR18","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1017\/S0031182017000993","volume":"145","author":"RL Charlton","year":"2018","unstructured":"Charlton RL, Rossi-Bergmann B, Denny PW, Steel PG (2018) Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art. Parasitology 145(2):219\u2013236. https:\/\/doi.org\/10.1017\/S0031182017000993","journal-title":"Parasitology"},{"issue":"1","key":"1597_CR19","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1021\/acsinfecdis.8b00226","volume":"5","author":"V Corpas-Lopez","year":"2019","unstructured":"Corpas-Lopez V, Moniz S, Thomas M, Wall RJ, Torrie LS, Zander-Dinse D, Tinti M, Brand S, Stojanovski L, Manthri S, Hallyburton I, Zuccotto F, Wyatt PG, De Rycker M, Horn D, Ferguson MAJ, Clos J, Read KD, Fairlamb AH, Wyllie S (2019) Pharmacological Validation of N-Myristoyltransferase as a Drug Target in Leishmania donovani. ACS Infect Dis 5(1):111\u2013122. https:\/\/doi.org\/10.1021\/acsinfecdis.8b00226","journal-title":"ACS Infect Dis"},{"key":"1597_CR20","doi-asserted-by":"publisher","unstructured":"Cosma C, Maia C, Khan N, Infantino M, Del Riccio M (2024) Leishmaniasis in Humans and Animals: A One Health Approach for Surveillance, Prevention and Control in a Changing World. In Tropical Medicine and Infectious Disease (Vol. 9, Issue 11). https:\/\/doi.org\/10.3390\/tropicalmed9110258","DOI":"10.3390\/tropicalmed9110258"},{"issue":"4","key":"1597_CR21","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1073\/pnas.1110339109","volume":"109","author":"HE Cummings","year":"2012","unstructured":"Cummings HE, Barbi J, Reville P, Oghumu S, Zorko N, Sarkar A, Keiser TL, Lu B, R\u00fcckle T, Varikuti S, Lezama-Davila C, Wewers MD, Whitacre C, Radzioch D, Rommel C, Seveau S, Satoskar AR (2012) Critical role for phosphoinositide 3-kinase gamma in parasite invasion and disease progression of cutaneous leishmaniasis. Proc Natl Acad Sci USA 109(4):1251\u20131256. https:\/\/doi.org\/10.1073\/pnas.1110339109","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"1597_CR22","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s40257-022-00726-8","volume":"23","author":"HJC de Vries","year":"2022","unstructured":"de Vries HJC, Schallig HD (2022) Cutaneous leishmaniasis: a 2022 updated narrative review into diagnosis and management developments. Am J Clin Dermatol 23(6):823\u2013840","journal-title":"Am J Clin Dermatol"},{"issue":"8","key":"1597_CR23","doi-asserted-by":"publisher","first-page":"e1297","DOI":"10.1371\/journal.pntd.0001297","volume":"5","author":"R Diaz-Gonzalez","year":"2011","unstructured":"Diaz-Gonzalez R, Kuhlmann FM, Galan-Rodriguez C, Madeira da Silva L, Saldivia M, Karver CE, Rodriguez A, Beverley SM, Navarro M, Pollastri MP (2011) The susceptibility of trypanosomatid pathogens to PI3\/mTOR kinase inhibitors affords a new opportunity for drug repurposing. PLoS Negl Trop Dis 5(8):e1297. https:\/\/doi.org\/10.1371\/journal.pntd.0001297","journal-title":"PLoS Negl Trop Dis"},{"key":"1597_CR24","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.compbiolchem.2016.08.007","volume":"64","author":"Y Ding","year":"2016","unstructured":"Ding Y, Fang Y, Moreno J, Ramanujam J, Jarrell M, Brylinski M (2016) Assessing the similarity of ligand binding conformations with the Contact Mode Score. Comput Biol Chem 64:403\u2013413. https:\/\/doi.org\/10.1016\/j.compbiolchem.2016.08.007","journal-title":"Comput Biol Chem"},{"issue":"8","key":"1597_CR25","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1063\/1.449071","volume":"83","author":"DJ Evans","year":"1985","unstructured":"Evans DJ, Holian BL (1985) The Nose\u2013Hoover thermostat. J Chem Phys 83(8):4069\u20134074. https:\/\/doi.org\/10.1063\/1.449071","journal-title":"J Chem Phys"},{"issue":"13","key":"1597_CR26","doi-asserted-by":"publisher","first-page":"3741","DOI":"10.1016\/j.bmcl.2013.05.007","volume":"23","author":"P Furet","year":"2013","unstructured":"Furet P, Guagnano V, Fairhurst RA, Imbach-Weese P, Bruce I, Knapp M, Fritsch C, Blasco F, Blanz J, Aichholz R, Hamon J, Fabbro D, Caravatti G (2013) Discovery of NVP-BYL719 a potent and selective phosphatidylinositol-3 kinase alpha inhibitor selected for clinical evaluation. Bioorg Med Chem Lett 23(13):3741\u20133748. https:\/\/doi.org\/10.1016\/j.bmcl.2013.05.007","journal-title":"Bioorg Med Chem Lett"},{"key":"1597_CR27","doi-asserted-by":"publisher","first-page":"109591","DOI":"10.1016\/j.intimp.2022.109591","volume":"114","author":"B Gopu","year":"2023","unstructured":"Gopu B, Kour P, Pandian R, Singh K (2023) Insights into the drug screening approaches in leishmaniasis. Int Immunopharmacol 114:109591. https:\/\/doi.org\/10.1016\/j.intimp.2022.109591","journal-title":"Int Immunopharmacol"},{"key":"1597_CR28","doi-asserted-by":"publisher","first-page":"1211473","DOI":"10.3389\/fendo.2023.1211473","volume":"14","author":"A Gulbins","year":"2023","unstructured":"Gulbins A, Horstmann M, Daser A, Fl\u00f6gel U, Oeverhaus M, Bechrakis NE, Banga JP, Keitsch S, Wilker B, Krause G (2023) Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease. Front Endocrinol 14:1211473","journal-title":"Front Endocrinol"},{"issue":"2","key":"1597_CR29","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1016\/j.sjbs.2021.10.019","volume":"29","author":"Y Guo","year":"2022","unstructured":"Guo Y, Mehrabi Nasab E, Hassanpour F, Athari SS (2022) Linsitinib and aspirin as the IGF1-R antagonists, inhibit regorafenib-resistant chemotherapy in colon cancer. Saudi J Biol Sci 29(2):872\u2013877. https:\/\/doi.org\/10.1016\/j.sjbs.2021.10.019","journal-title":"Saudi J Biol Sci"},{"issue":"1","key":"1597_CR30","doi-asserted-by":"publisher","first-page":"2549802","DOI":"10.1080\/21505594.2025.2549802","volume":"16","author":"D Gurjar","year":"2025","unstructured":"Gurjar D, Bodhale N, Shukla D, Nayak D, Lenka N, Saha B (2025) Manipulation of macrophage signaling by Leishmania virulence factors. Virulence 16(1):2549802. https:\/\/doi.org\/10.1080\/21505594.2025.2549802","journal-title":"Virulence"},{"key":"1597_CR31","doi-asserted-by":"publisher","unstructured":"Intakhan N, Chanmol W, Somboon P, Bates MD, Yardley V, Bates PA, Jariyapan N (2020) Antileishmanial Activity and Synergistic Effects of Amphotericin B Deoxycholate with Allicin and Andrographolide against Leishmania martiniquensis In Vitro. In Pathogens (Vol. 9, Issue 1, p. 49). https:\/\/doi.org\/10.3390\/pathogens9010049","DOI":"10.3390\/pathogens9010049"},{"key":"1597_CR32","doi-asserted-by":"publisher","first-page":"1454002","DOI":"10.3389\/fcimb.2024.1454002","volume":"14","author":"M Jain","year":"2024","unstructured":"Jain M, Sangma DA, Parida L, Negi R, Negi A, Matlashewski G, Lypaczewski P (2024) Atypical cutaneous leishmaniasis: a new challenge to VL elimination in South-East Asia. Front Cell Infect Microbiol 14:1454002. https:\/\/doi.org\/10.3389\/fcimb.2024.1454002","journal-title":"Front Cell Infect Microbiol"},{"key":"1597_CR33","doi-asserted-by":"publisher","first-page":"S153","DOI":"10.1016\/j.vaccine.2023.01.057","volume":"41","author":"PM Kaye","year":"2023","unstructured":"Kaye PM, Matlashewski G, Mohan S, Le Rutte E, Mondal D, Khamesipour A, Malvolti S (2023) Vaccine value profile for leishmaniasis. Vaccine 41:S153\u2013S175. https:\/\/doi.org\/10.1016\/j.vaccine.2023.01.057","journal-title":"Vaccine"},{"issue":"D1","key":"1597_CR34","doi-asserted-by":"publisher","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","volume":"44","author":"S Kim","year":"2016","unstructured":"Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A, Han L, He J, He S, Shoemaker BA, Wang J, Yu B, Zhang J, Bryant SH (2016) PubChem Substance and Compound databases. Nucleic Acids Res 44(D1):D1202\u2013D1213. https:\/\/doi.org\/10.1093\/nar\/gkv951","journal-title":"Nucleic Acids Res"},{"key":"1597_CR35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.cellimm.2016.09.004","volume":"309","author":"PE Kima","year":"2016","unstructured":"Kima PE (2016) PI3K signaling in Leishmania infections. Cell Immunol 309:19\u201322. https:\/\/doi.org\/10.1016\/j.cellimm.2016.09.004","journal-title":"Cell Immunol"},{"issue":"21","key":"1597_CR36","doi-asserted-by":"publisher","first-page":"e3410","DOI":"10.21769\/BioProtoc.3410","volume":"9","author":"OS Koutsoni","year":"2019","unstructured":"Koutsoni OS, Karampetsou K, Dotsika E (2019) In vitro Screening of Antileishmanial Activity of Natural Product Compounds: Determination of IC(50), CC(50) and SI Values. Bio-Protocol 9(21):e3410. https:\/\/doi.org\/10.21769\/BioProtoc.3410","journal-title":"Bio-Protocol"},{"key":"1597_CR37","doi-asserted-by":"publisher","first-page":"108688","DOI":"10.1016\/j.exppara.2023.108688","volume":"257","author":"V Kumar","year":"2024","unstructured":"Kumar V, Kumari S, Ranjan R, Kumar A, Alti D (2024) In vitro antileishmanial activity of thioridazine on amphotericin B unresponsive\/ sensitive Leishmania donovani promastigotes and intracellular amastigotes. Exp Parasitol 257:108688. https:\/\/doi.org\/10.1016\/j.exppara.2023.108688","journal-title":"Exp Parasitol"},{"key":"1597_CR38","doi-asserted-by":"publisher","first-page":"107338","DOI":"10.1016\/j.actatropica.2024.107338","volume":"258","author":"D Kumari","year":"2024","unstructured":"Kumari D, Jamwal V, Singh A, Singh SK, Mujwar S, Ansari MY, Singh K (2024) Repurposing FDA approved drugs against Sterol C-24 methyltransferase of Leishmania donovani: A dual in silico and in vitro approach. Acta Trop 258:107338. https:\/\/doi.org\/10.1016\/j.actatropica.2024.107338","journal-title":"Acta Trop"},{"issue":"12","key":"1597_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0311093","volume":"19","author":"J-Y Lee","year":"2024","unstructured":"Lee J-Y, Lee S-B, Yang S-W, Paik J-S (2024) Linsitinib inhibits IGF-1-induced cell proliferation and hyaluronic acid secretion by suppressing PI3K\/Akt and ERK pathway in orbital fibroblasts from patients with thyroid-associated ophthalmopathy. PLoS ONE 19(12):1\u201312. https:\/\/doi.org\/10.1371\/journal.pone.0311093","journal-title":"PLoS ONE"},{"issue":"7","key":"1597_CR40","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","volume":"17","author":"C Lu","year":"2021","unstructured":"Lu C, Wu C, Ghoreishi D, Chen W, Wang L, Damm W, Ross GA, Dahlgren MK, Russell E, Von Bargen CD, Abel R, Friesner RA, Harder ED (2021) OPLS4: Improving Force Field Accuracy on Challenging Regimes of Chemical Space. J Chem Theory Comput 17(7):4291\u20134300. https:\/\/doi.org\/10.1021\/acs.jctc.1c00302","journal-title":"J Chem Theory Comput"},{"key":"1597_CR41","doi-asserted-by":"publisher","unstructured":"Luffy M, Ganz A-L, Wagner S, Wolf J, Ropertz J, Zeidan R, Kent JD, Douglas RS, Kahaly GJ (2024) Linsitinib inhibits proliferation and induces apoptosis of both IGF-1R and TSH-R expressing cells. Frontiers in Immunology. 15. https:\/\/doi.org\/10.3389\/fimmu.2024.1488220","DOI":"10.3389\/fimmu.2024.1488220"},{"issue":"12","key":"1597_CR42","doi-asserted-by":"publisher","first-page":"2897","DOI":"10.1158\/1078-0432.CCR-15-2218","volume":"22","author":"VM Macaulay","year":"2016","unstructured":"Macaulay VM, Middleton MR, Eckhardt SG, Rudin CM, Juergens RA, Gedrich R, Gogov S, McCarthy S, Poondru S, Stephens AW, Gadgeel SM (2016) Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors. Clin Cancer Research: Official J Am Association Cancer Res 22(12):2897\u20132907. https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-2218","journal-title":"Clin Cancer Research: Official J Am Association Cancer Res"},{"key":"1597_CR43","doi-asserted-by":"publisher","first-page":"e00270","DOI":"10.1016\/j.parepi.2022.e00270","volume":"19","author":"H Mahmoudvand","year":"2022","unstructured":"Mahmoudvand H, Ghasemian Yadegari J, Khalaf AK, Hashemi MJ, Dastyarhaghighi S, Salimikia I (2022) Chemical composition, antileishmanial, and cytotoxic effects Ferula macrecolea essential oil against Leishmania tropica. Parasite Epidemiol Control 19:e00270. https:\/\/doi.org\/10.1016\/j.parepi.2022.e00270","journal-title":"Parasite Epidemiol Control"},{"issue":"43","key":"1597_CR44","doi-asserted-by":"publisher","first-page":"9954","DOI":"10.1021\/jp003020w","volume":"105","author":"P Mark","year":"2001","unstructured":"Mark P, Nilsson L (2001) Structure and Dynamics of the TIP3P, SPC, and SPC\/E Water Models at 298 K. J Phys Chem A 105(43):9954\u20139960. https:\/\/doi.org\/10.1021\/jp003020w","journal-title":"J Phys Chem A"},{"issue":"11","key":"1597_CR45","doi-asserted-by":"publisher","first-page":"e00756","DOI":"10.1128\/aac.00756-24","volume":"68","author":"RJ Martins","year":"2024","unstructured":"Martins RJ, de Morais TE, Leidicy AL, Rocha A\u00c9A, Ant\u00f4nio P-XM, Murta SAM, Edward O, Goulart GPP, Andrea T-C, Fonseca MSM, Vanessa P-M, Maria S-FE (2024) Can letrozole be repurposed for the treatment of visceral leishmaniasis? Antimicrob Agents Chemother 68(11):e00756\u2013e00724. https:\/\/doi.org\/10.1128\/aac.00756-24","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1597_CR46","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/00268970110088947","volume":"100","author":"IR McDONALD","year":"2002","unstructured":"McDONALD IR (2002) NpT-ensemble Monte Carlo calculations for binary liquid mixtures. Mol Phys 100(1):95\u2013105. https:\/\/doi.org\/10.1080\/00268970110088947","journal-title":"Mol Phys"},{"issue":"11","key":"1597_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0206920","volume":"13","author":"D Nandan","year":"2018","unstructured":"Nandan D, Zhang N, Yu Y, Schwartz B, Chen S, Kima PE, Reiner NE (2018) Miransertib (ARQ 092), an orally-available, selective Akt inhibitor is effective against Leishmania. PLoS ONE 13(11):1\u201316. https:\/\/doi.org\/10.1371\/journal.pone.0206920","journal-title":"PLoS ONE"},{"key":"1597_CR49","doi-asserted-by":"publisher","first-page":"115550","DOI":"10.1016\/j.ejmech.2023.115550","volume":"258","author":"IJ Nascimento","year":"2023","unstructured":"Nascimento IJ, dos S, de Cavalcanti M A. T., de Moura RO (2023) Exploring N-myristoyltransferase as a promising drug target against parasitic neglected tropical diseases. Eur J Med Chem 258:115550. https:\/\/doi.org\/10.1016\/j.ejmech.2023.115550","journal-title":"Eur J Med Chem"},{"key":"1597_CR50","doi-asserted-by":"publisher","first-page":"107820","DOI":"10.1016\/j.actatropica.2025.107820","volume":"270","author":"L Nharwal","year":"2025","unstructured":"Nharwal L, Beg MA, Sehgal D, Singh OP, Tiwari A, Selvapandiyan A, Chouhan G (2025) Emerging trends and Innovative strategies for the diagnosis of Leishmaniasis: A quantum leap from classical to modern era. Acta Trop 270:107820. https:\/\/doi.org\/10.1016\/j.actatropica.2025.107820","journal-title":"Acta Trop"},{"issue":"3","key":"1597_CR60","doi-asserted-by":"publisher","first-page":"e70170","DOI":"10.1111\/cbdd.70170","volume":"106","author":"Sant\u2019AnnaP Nicolau","year":"2025","unstructured":"Nicolau Sant\u2019AnnaP, Resende M, de Campos Chaves MA, Rodrigues C, de Melo Rodrigues RS, Nicolau-Junior V, N., Yoneyama KAG (2025) Investigation of Potential Inhibitors of N-Myristoyltransferase in Leishmania amazonensis: A Computational and Experimental Study. Chem Biology \\& Drug Des 106(3):e70170. https:\/\/doi.org\/10.1111\/cbdd.70170","journal-title":"Chem Biology \\& Drug Des"},{"key":"1597_CR51","doi-asserted-by":"publisher","unstructured":"Ochoa R, Ortega-Pajares A, Castello FA, Serral F, Fern\u00e1ndez Do Porto D, Villa-Pulgarin JA, Varela-M RE, Muskus C (2021) Identification of Potential Kinase Inhibitors within the PI3K\/AKT Pathway of Leishmania Species. In Biomolecules (Vol. 11, Issue 7). https:\/\/doi.org\/10.3390\/biom11071037","DOI":"10.3390\/biom11071037"},{"key":"1597_CR52","doi-asserted-by":"publisher","unstructured":"Ol\u00edas-Molero AI, de la Fuente C, Cuquerella M, Torrado JJ, Alunda JM (2021) Antileishmanial Drug Discovery and Development: Time to Reset the Model? Microorganisms 9(12). https:\/\/doi.org\/10.3390\/microorganisms9122500","DOI":"10.3390\/microorganisms9122500"},{"issue":"1","key":"1597_CR53","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s13071-020-3999-1","volume":"13","author":"D Paape","year":"2020","unstructured":"Paape D, Prendergast CT, Price HP, Doehl JSP, Smith DF (2020) Genetic validation of Leishmania genes essential for amastigote survival in vivo using N-myristoyltransferase as a model. Parasites Vectors 13(1):132. https:\/\/doi.org\/10.1186\/s13071-020-3999-1","journal-title":"Parasites Vectors"},{"issue":"13","key":"1597_CR54","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE (2004) UCSF Chimera\u2014A visualization system for exploratory research and analysis. J Comput Chem 25(13):1605\u20131612. https:\/\/doi.org\/10.1002\/jcc.20084","journal-title":"J Comput Chem"},{"key":"1597_CR55","doi-asserted-by":"publisher","unstructured":"Phan T-N, Baek K-H, Lee N, Byun SY, Shum D, No JH (2020) In Vitro and in Vivo Activity of mTOR Kinase and PI3K Inhibitors Against Leishmania donovani and Trypanosoma brucei. In Molecules (Vol. 25, Issue 8, p. 1980). https:\/\/doi.org\/10.3390\/molecules25081980","DOI":"10.3390\/molecules25081980"},{"issue":"21","key":"1597_CR56","doi-asserted-by":"publisher","first-page":"8965","DOI":"10.1007\/s00253-020-10856-w","volume":"104","author":"BM Roatt","year":"2020","unstructured":"Roatt BM, de Oliveira Cardoso JM, De Brito RCF, Coura-Vital W, de Oliveira Aguiar-Soares RD, Reis AB (2020) Recent advances and new strategies on leishmaniasis treatment. Appl Microbiol Biotechnol 104(21):8965\u20138977. https:\/\/doi.org\/10.1007\/s00253-020-10856-w","journal-title":"Appl Microbiol Biotechnol"},{"issue":"1","key":"1597_CR57","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.exppara.2008.12.010","volume":"122","author":"A Ruhland","year":"2009","unstructured":"Ruhland A, Kima PE (2009) Activation of PI3K\/Akt signaling has a dominant negative effect on IL-12 production by macrophages infected with Leishmania amazonensis promastigotes. Exp Parasitol 122(1):28\u201336. https:\/\/doi.org\/10.1016\/j.exppara.2008.12.010","journal-title":"Exp Parasitol"},{"issue":"1","key":"1597_CR58","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1111\/j.1462-5822.2006.00769.x","volume":"9","author":"A Ruhland","year":"2007","unstructured":"Ruhland A, Leal N, Kima PE (2007) Leishmania promastigotes activate PI3K\/Akt signalling to confer host cell resistance to apoptosis. Cell Microbiol 9(1):84\u201396. https:\/\/doi.org\/10.1111\/j.1462-5822.2006.00769.x","journal-title":"Cell Microbiol"},{"issue":"7","key":"1597_CR59","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1093\/jac\/dku069","volume":"69","author":"L Sanderson","year":"2014","unstructured":"Sanderson L, Yardley V, Croft SL (2014) Activity of anti-cancer protein kinase inhibitors against Leishmania spp. J Antimicrob Chemother 69(7):1888\u20131891. https:\/\/doi.org\/10.1093\/jac\/dku069","journal-title":"J Antimicrob Chemother"},{"issue":"14","key":"1597_CR61","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1017\/S0031182015001389","volume":"142","author":"A Selvapandiyan","year":"2015","unstructured":"Selvapandiyan A, Ahuja K, Puri N, Krishnan A (2015) Implications of co-infection of Leptomonas in visceral leishmaniasis in India. Parasitology 142(14):1657\u20131662. https:\/\/doi.org\/10.1017\/S0031182015001389","journal-title":"Parasitology"},{"key":"1597_CR62","doi-asserted-by":"publisher","first-page":"118276","DOI":"10.1016\/j.bmc.2025.118276","volume":"128","author":"M Shahid","year":"2025","unstructured":"Shahid M, Nharwal L, Fayaz H, Ahuja Y, Beg MA, Jain P, Chouhan G, Selvapandiyan A (2025) Targeting MAP kinase for inhibiting Leishmania promastigotes and amastigotes stages by L-alanine derived molecules and their anticancer potential against PANC-1 cancer cell lines. Bioorg Med Chem 128:118276. https:\/\/doi.org\/10.1016\/j.bmc.2025.118276","journal-title":"Bioorg Med Chem"},{"key":"1597_CR63","doi-asserted-by":"publisher","first-page":"590544","DOI":"10.3389\/fphar.2020.590544","volume":"11","author":"DKC Silva","year":"2020","unstructured":"Silva DKC, Teixeira JS, Moreira DRM, Da Silva TF, Barreiro EJdeL, Freitas HFde, Pita SSdaR, Teles ALB, Guimar\u00e3es ET, Soares MBP (2020) In vitro, in vivo and in silico effectiveness of LASSBio-1386, an N-acyl hydrazone derivative phosphodiesterase-4 inhibitor, against Leishmania amazonensis. Front Pharmacol 11:590544","journal-title":"Front Pharmacol"},{"key":"1597_CR64","doi-asserted-by":"publisher","unstructured":"Singh R, Kashif M, Srivastava P, Manna PP (2023) Recent Advances in Chemotherapeutics for Leishmaniasis: Importance of the Cellular Biochemistry of the Parasite and Its Molecular Interaction with the Host. In Pathogens (Vol. 12, Issue 5, p. 706). https:\/\/doi.org\/10.3390\/pathogens12050706","DOI":"10.3390\/pathogens12050706"},{"key":"1597_CR65","doi-asserted-by":"publisher","DOI":"10.1007\/s11030-025-11332-1","author":"R Singh","year":"2025","unstructured":"Singh R, Tripathi V, Dwivedi VD, Chouhan G (2025) Mechanistic inhibition of FtsZ-driven bacterial cytokinesis by natural products: an integrated machine learning and advanced drug discovery approach. Mol Diversity. https:\/\/doi.org\/10.1007\/s11030-025-11332-1","journal-title":"Mol Diversity"},{"issue":"3","key":"1597_CR66","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s12639-023-01605-7","volume":"47","author":"S Tandon","year":"2023","unstructured":"Tandon S, Puri M, Bharath Y, Choudhury UM, Mohapatra DK, Muthuswami R, Madhubala R (2023) In vitro screening of natural product-based compounds for leishmanicidal activity. J Parasitic Diseases: Official Organ Indian Soc Parasitol 47(3):644\u2013658. https:\/\/doi.org\/10.1007\/s12639-023-01605-7","journal-title":"J Parasitic Diseases: Official Organ Indian Soc Parasitol"},{"key":"1597_CR67","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21334","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. https:\/\/doi.org\/10.1002\/jcc.21334., NA-NA","journal-title":"J Comput Chem"},{"key":"1597_CR47","doi-asserted-by":"publisher","unstructured":"von Mehren M, George S, Heinrich MC, Schuetze SM, Yap JT, Yu2 JQ, Abbott A, Litwin S, Crowley J, Janeway GM, Hornick KA, Flieder JL, Chugh DB, Rink R, L. A., Abbeele AA Van den. (2018). Linsitinib (OSI-906) for the treatment of Adult and Pediatric Wild Type Gastrointestinal Stromal Tumors, a SARC Phase II study. Physiol Behav, 176(1), 100\u2013106. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-1069.Linsitinib","DOI":"10.1158\/1078-0432.CCR-19-1069.Linsitinib"},{"issue":"3","key":"1597_CR68","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.chembiol.2015.01.003","volume":"22","author":"MH Wright","year":"2015","unstructured":"Wright MH, Paape D, Storck EM, Serwa RA, Smith DF, Tate EW (2015) Global analysis of protein N-myristoylation and exploration of N-myristoyltransferase as a drug target in the neglected human pathogen Leishmania donovani. Chem Biol 22(3):342\u2013354. https:\/\/doi.org\/10.1016\/j.chembiol.2015.01.003","journal-title":"Chem Biol"},{"key":"1597_CR69","doi-asserted-by":"publisher","first-page":"115084","DOI":"10.1016\/j.intimp.2025.115084","volume":"161","author":"T Zhu","year":"2025","unstructured":"Zhu T, Pan M, Ding Q, Ding J, Wang B, Li Z, Yang L, Zhang C, Chen Z, Jin B, Yu G, Chen C, Xu Y (2025) Targeting insulin-like growth factor 1 signaling with Linsitinib to modulate fibroblast plasticity and attenuate pulmonary fibrosis. Int Immunopharmacol 161:115084. https:\/\/doi.org\/10.1016\/j.intimp.2025.115084","journal-title":"Int Immunopharmacol"}],"container-title":["Folia Microbiologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-026-01597-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12223-026-01597-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-026-01597-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:03:24Z","timestamp":1790982204000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12223-026-01597-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":69,"alternative-id":["1597"],"URL":"https:\/\/doi.org\/10.1007\/s12223-026-01597-w","relation":{},"ISSN":["0015-5632","1874-9356"],"issn-type":[{"value":"0015-5632","type":"print"},{"value":"1874-9356","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]},"assertion":[{"value":"7 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"<b>Competing interests<\/b>","group":{"name":"EthicsHeading","label":"Declarations"}}]}}